Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.

Nishioka, Scott T; Sato, Miles M; Wong, Linda L; Tiirikainen, Maarit; Kwee, Sandi A

Nishioka, Scott T; Sato, Miles M; Wong, Linda L; Tiirikainen, Maarit; Kwee, Sandi A.

Afiliación

Nishioka ST; The Queen's Medical Center, Honolulu, HI 96813, USA.
Sato MM; The Queen's Medical Center, Honolulu, HI 96813, USA.
Wong LL; Cancer Biology Program and Genomics Shared Resource, University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI 96822, USA.
Tiirikainen M; Cancer Biology Program and Genomics Shared Resource, University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI 96822, USA.
Kwee SA; The Queen's Medical Center, Honolulu, HI 96813, USA.

Hepatoma Res ; 42018.

Article en En | MEDLINE | ID: mdl-29376136

Palabras clave

Asia-Pacific; Hawaii; Hepatocellular carcinoma; alpha-fetoprotein; enrichment analysis; gene expression; molecular signature; survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatoma Res Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google